Global Epigenetics Drugs And Diagnostic Technologies Market Report By Drugs Mechanism Of Action (DNMT Inhibitors And HDAC Inhibitors), Technology Type (DNA Methylation And Chromatin Immunoprecipitation (CHIP) Technology), And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2018-2025
ID:VMR11210484
February 2019
Report Formats:
As per this study the global epigenetics drugs and diagnostic technologies market was valued USD XX.X MN (by revenue) in 2018 and is anticipated to reach USD XX.X MN by 2025 with a CAGR of X.X%.
Epigenetics is a study of heritable changes in gene expression, it’s a change in phenotype without a change in genotype. Epigenetics drugs and diagnostic is used in screening of early stage cancer and other abnormal changes in skin cells, liver cells, brain cells, and others. It is caused by various factors such as aging and lifestyle changes along with environmental exposures.
Market Dynamics
The increasing geriatric population and rising oncology and non-oncology disorders are driving the market growth. Also, the high prevalence of cancer with advancement is screening techniques is further fuelling market growth. In addition, reduction in sequential cost and time is another factor pushing the market growth. Though, the funding and support of the organizations such as NIH and NCI for R&D are expected to boost the market growth in the forecast period. However, problems associated with quality may hamper market growth.
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of epigenetics drugs and diagnostic technologies.
Market Segmentation
The broad epigenetics drugs and diagnostic technologies market has been sub-grouped into drugs mechanism of action and technology type. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
By Drugs Mechanism Of Action
- DNMT Inhibitors
- Azacitidine (Vidaza)
- Decitabine (Dacogen)
- HDAC Inhibitors
- Vorinostat (Zolinza)
- Romidepsin (Istodax)
By Technology Types
- DNA Methylation
- Chromatin Immunoprecipitation (ChIP) Technology
Regional Analysis
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for epigenetics drugs and diagnostic technologies in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
Europe Epigenetics Drugs And Diagnostic Technologies Market By Revenue (USD MN)
The report also covers a detailed competitive landscape including company profiles of key players operating in the global market. The key players in the epigenetics drugs and diagnostic technologies market include 4SC AG, Acetylon Pharmaceuticals, Inc., Astex Pharmaceuticals Inc., Celenge, CellCentric Ltd., Celleron Therapeutics Ltd., Chroma Therapeutics Ltd., Eisai Pharmaceuticals, EnVivo Pharmaceuticals Inc., Epigentek Group Inc., Epizyme, Inc. Illumina Inc., MDxHealth, Merck, Merck & Company Inc., Novartis International AG, Oncolys BioPharma Inc., Pharmacyclics, Promega Corporation, Spectrum Pharmaceuticals, Syndax Pharmaceuticals, Inc., Topotarget A/S, and Valirx Plc. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
METHODOLOGY:
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.
1. INTRODUCTION
- Introduction To Epigenetics Drugs And Diagnostic Technologies
- Report Description
- Objectives Of The Study
- Assumptions
- Research Scope
- Research Methodology
- Data Source
2. EXECUTIVE SUMMARY
- Market Highlight
- Global Epigenetics Drugs And Diagnostic Technologies Market: Snapshot
3. MARKET ANALYSIS
- Drivers
- Restraints
- Opportunities
- Porter’s Five Forces Analysis
- Value Chain Analysis
4. EPIGENETICS DRUGS AND DIAGNOSTIC TECHNOLOGIES MARKET ANALYSIS BY DRUGS MECHANISM OF ACTION
- Market In DNMT Inhibitors
- Market In Azacitidine (Vidaza)
- Market In Decitabine (Dacogen)
- Market In HDAC Inhibitors
- Market In Vorinostat (Zolinza)
- Market In Romidepsin (Istodax)
5. EPIGENETICS DRUGS AND DIAGNOSTIC TECHNOLOGIES MARKET ANALYSIS BY TECHNOLOGY TYPES
- Market In DNA Methylation
- Market In Chromatin Immunoprecipitation (ChIP) Technology
6. EPIGENETICS DRUGS AND DIAGNOSTIC TECHNOLOGIES MARKET ANALYSIS BY GEOGRAPHY
- North America (NA)
- North America Market Estimates
- North America Market Estimates By Country
- United States (U.S.) Market Estimates By Segments
- Rest Of North America Market Estimates By Segments
- Europe (EU)
- Europe Market Estimates
- Europe Market Estimates By Country
- United Kingdom (UK) Market Estimates By Segments
- Germany Market Estimates By Segments
- France Market Estimates By Segments
- Rest Of Europe Market Estimates By Segments
- Asia Pacific (APAC)
- Asia Pacific Market Estimates
- Asia Pacific Market Estimates By Country
- China Market Estimates By Segments
- Japan Market Estimates By Segments
- India Market Estimates By Segments
- Rest Of Asia Pacific Market Estimates By Segments
- Latin America (LA)
- Latin America Market Estimates
- Latin America Market Estimates By Country
- Brazil Market Estimates By Segments
- Rest Of Latin America Market Estimates By Segments
- Middle East And Africa (MEA)
- Middle East And Africa Market Estimates
- Middle East And Africa Market Estimates By Country
- Middle East Market Estimates By Segments
- Africa Market Estimates By Segments
7. COMPETITIVE LANDSCAPE OF THE EPIGENETICS DRUGS AND DIAGNOSTIC TECHNOLOGIES COMPANIES
- Market Competition
- Partnerships/Collaborations/Agreements
- Mergers And Acquisitions
- New Product Launches
- Other Developments
8. COMPANY PROFILES OF THE EPIGENETICS DRUGS AND DIAGNOSTIC TECHNOLOGIES INDUSTRY (Company Overview, Financial, Major Products & Recent Development)
- 4SC AG
- Acetylon Pharmaceuticals, Inc.
- Astex Pharmaceuticals Inc.
- Celenge
- CellCentric Ltd.
- Celleron Therapeutics Ltd.
- Chroma Therapeutics Ltd.
- Eisai Pharmaceuticals
- EnVivo Pharmaceuticals Inc.
- Epigentek Group Inc.
- Epizyme, Inc. Illumina Inc.
- MDxHealth
- Merck
- Merck & Company Inc.
- Novartis International AG
- Oncolys BioPharma Inc.
- Pharmacyclics
- Promega Corporation
- Spectrum Pharmaceuticals
- Syndax Pharmaceuticals, Inc.
- Topotarget A/S
- Valirx Plc
* Tentative TOC
LIST OF TABLES
Table 1. Market Highlights Of Epigenetics Drugs And Diagnostic Technologies
Table 2. Global Epigenetics Drugs And Diagnostic Technologies Market By Drugs Mechanism Of Action
Table 3. Global Epigenetics Drugs And Diagnostic Technologies Market By Technology Types
Table 4. Global Epigenetics Drugs And Diagnostic Technologies Market By Geography
Table 5. North America Epigenetics Drugs And Diagnostic Technologies Market
Table 6. Europe Epigenetics Drugs And Diagnostic Technologies Market
Table 7. Asia Pacific Epigenetics Drugs And Diagnostic Technologies Market
Table 8. Latin America Epigenetics Drugs And Diagnostic Technologies Market
Table 9. Middle East And Africa Epigenetics Drugs And Diagnostic Technologies Market
Table 10. Partnership/Collaboration/Agreements
Table 11. Mergers And Acquisitions
Table 12. New Product Development
Table 13. Other Developments
LIST OF FIGURES
Fig. 1. Market Segmentation Of Epigenetics Drugs And Diagnostic Technologies Market
Fig. 2. Top-Down Approach
Fig. 3. Bottom-Up Approach
Fig. 4. Market Highlights Of Epigenetics Drugs And Diagnostic Technologies
Fig. 5. Porter’s Five Forces Analysis
Fig. 6. Value Chain Analysis
Fig. 7. Global Epigenetics Drugs And Diagnostic Technologies Market By Drugs Mechanism Of Action
Fig. 8. Global Epigenetics Drugs And Diagnostic Technologies Market By Technology Types
Fig. 9. Global Epigenetics Drugs And Diagnostic Technologies Market By Geography
Fig. 10. North America Epigenetics Drugs And Diagnostic Technologies Market
Fig. 11. Europe Epigenetics Drugs And Diagnostic Technologies Market
Fig. 12. Asia Pacific Epigenetics Drugs And Diagnostic Technologies Market
Fig. 13. Latin America Epigenetics Drugs And Diagnostic Technologies Market
Fig. 14. Middle East And Africa Epigenetics Drugs And Diagnostic Technologies Market
Fig. 15. Market Share Of Epigenetics Drugs And Diagnostic Technologies Companies
Fig. 16. Recent Developments In Epigenetics Drugs And Diagnostic Technologies Industry
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
Objectives of Study
- Define and measure the global market
- Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
- Analyze and identify major market trends along with the factors driving or inhibiting the market growth
- Study the company profiles of the major market players with their market share
- Analyze competitive developments
Buy Chapters or Sections
Avail customized purchase options to meet your exact research needs:
- Buy sections of this report
- Buy country level reports
- Request for historical data
- Request discounts available for Start-Ups & Universities
